Clinical efficacy of decitabine in combination with standard-dose cytarabine, aclarubicin hydrochloride, and granulocyte colony-stimulating factor in the treatment of young patients with newly diagnosed acute myeloid leukemia

Purpose: The chemotherapeutic regimen DCAG (decitabine with cytarabine, aclarubicin hydrochloride, and granulocyte colony-stimulating factor) is effective for elderly patients with acute myeloid leukemia, but recommendations for young patients remain controversial. This study investigated the tolera...

Descripción completa

Detalles Bibliográficos
Autores principales: Dou, Liping, Xu, Qingyu, Wang, Mengzhen, Xiao, Yang, Cheng, Longcan, Li, Honghua, Huang, Wenrong, Mei, Junhui, Jing, Yu, Bo, Jian, Liu, Daihong, Yu, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605041/
https://www.ncbi.nlm.nih.gov/pubmed/31303761
http://dx.doi.org/10.2147/OTT.S200005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605041/
https://www.ncbi.nlm.nih.gov/pubmed/31303761
http://dx.doi.org/10.2147/OTT.S200005

Ejemplares similares